Cbfa1 mediates mesenchymal cell commitment to an osteochondroprogenitor lineage and supports continued differentiation and function in committed osteoblasts. However, definitive downstream mediators of Cbfa1 that critically impact osteoblast differentiation and bone formation have yet to be described. Ne1 (a protein strongly expressed in neural tissue encoding epidermal growth factor like domain) was first identified in chicken embryos. The preliminary data shows that Nell-1 (Ne1-like molecule-1) in vivo is associated with normal and pathological suture fusion, while Nell- 1 in vitro is associated with increased osteoblast differentiation and mineralization. Furthermore, the human Nell-1 promoter contains three osteoblast-specific cis-acting element 2 (OSE2) response elements for Cbfa1 and that Nell-1 overexpression mice can functionally compensate for some aspects of intramembranous bone deficiency in heterozygous Cbfa1 deficient mice. These data have led to the hypothesis that Nell-1 is a central downstream target of Cbfa1 that supports continued differentiation and function in committed osteoblasts and proper Nell-1 expression is required for normal membranous bone growth and formation. To test this hypothesis, this proposal will analyze the following: 1) the regulation of Nell-1 transcription by Cbfa1 during osteoblast formation and function and by Cbfa1 through OSE2 response elements; 2) the functional compensation of Cbfa1 deficiency by Nell-1 in vivo and in vitro; and 3) the effects of targeted Nell-1 disruption in vivo. If Nell-1 is proven to be a critical mediator of intramembranous bone formation, it can further aid in understanding the development of intramembranous vs. endochondral bone. In addition, since sutures are major sites of calvarial intramembranous bone growth the close association of Nell-1 with calvarial sutures can also impact present knowledge on cranial vault development. Lastly, Nell-1 can be tremendously useful as a clinical tool to inhibit or induce intramembranous bone growth, with the secretory nature of Nell-1 making this utility even more feasible. Controlled inhibition of intramembranous bone growth by anti-Nell-1 strategies in CS patients may offer a less invasive, biologically based, therapeutic alternative to radical surgical craniofacial reconstruction. In addition, the ability of Nell- 1 to induce calvarial osteoblast differentiation may be clinically applied to situations where membranous bone formation and regeneration are desirable (e.g., cleft lip or cleft palate repair and craniofacial distraction osteogenesis).

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE016107-02
Application #
6899379
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Small, Rochelle K
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$347,625
Indirect Cost
Name
University of California Los Angeles
Department
Dentistry
Type
Schools of Dentistry
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Pan, Hsin Chuan; Lee, Soonchul; Ting, Kang et al. (2017) Cyst-Like Osteolytic Formations in Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Augmented Sheep Spinal Fusion. Am J Pathol 187:1485-1495
Kwak, Jinny; Zara, Janette N; Chiang, Michael et al. (2013) NELL-1 injection maintains long-bone quantity and quality in an ovariectomy-induced osteoporotic senile rat model. Tissue Eng Part A 19:426-36
Siu, Ronald K; Zara, Janette N; Hou, Yaping et al. (2012) NELL-1 promotes cartilage regeneration in an in vivo rabbit model. Tissue Eng Part A 18:252-61
Zhang, Xinli; Ting, Kang; Pathmanathan, Dharmini et al. (2012) Calvarial cleidocraniodysplasia-like defects with ENU-induced Nell-1 deficiency. J Craniofac Surg 23:61-6
Zara, Janette N; Siu, Ronald K; Zhang, Xinli et al. (2011) High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 17:1389-99
Chen, Weiwei; Zhang, Xinli; Siu, Ronald K et al. (2011) Nfatc2 is a primary response gene of Nell-1 regulating chondrogenesis in ATDC5 cells. J Bone Miner Res 26:1230-41
Zou, Xuan; Shen, Jia; Chen, Feng et al. (2011) NELL-1 binds to APR3 affecting human osteoblast proliferation and differentiation. FEBS Lett 585:2410-8
James, Aaron W; Pan, Angel; Chiang, Michael et al. (2011) A new function of Nell-1 protein in repressing adipogenic differentiation. Biochem Biophys Res Commun 411:126-31
Siu, Ronald K; Lu, Steven S; Li, Weiming et al. (2011) Nell-1 protein promotes bone formation in a sheep spinal fusion model. Tissue Eng Part A 17:1123-35
Zheng, Zhong; Yin, Wei; Zara, Janette N et al. (2010) The use of BMP-2 coupled - Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials 31:9293-300

Showing the most recent 10 out of 25 publications